Which patient is going to benefit from surgical cytoreduction with intraperitoneal chemotherapy (for manifest peritoneal metastases)?
and
Mar 09, 2018
About this article
Published Online: Mar 09, 2018
Page range: 207 - 210
Received: Dec 18, 2017
Accepted: Dec 29, 2017
DOI: https://doi.org/10.1515/cipms-2017-0040
Keywords
© 2017 Sebastian Blaj et al., published by De Gruyter Open
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.
Blaj, Sebastian
Klinik für Allgemein- und Viszeralchirurgie, Krankenhaus Barmherzige Brüder RegensburgRegensburg, Germany
Piso, Pompiliu
Klinik für Allgemein- und Viszeralchirurgie, Krankenhaus Barmherzige Brüder RegensburgRegensburg, Germany